• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Serum titers of IgG antibodies against tetanus and diphtheria toxoids and risk of multiple sclerosis.抗破伤风和白喉类毒素IgG抗体的血清滴度与多发性硬化症风险
J Neuroimmunol. 2009 Mar 31;208(1-2):141-2. doi: 10.1016/j.jneuroim.2009.01.006. Epub 2009 Feb 7.
2
Intrathecal synthesis of antibodies to diphtheria and tetanus toxoids in multiple sclerosis patients.
J Neuroimmunol. 1981 Sep;1(3):333-41. doi: 10.1016/0165-5728(81)90036-9.
3
Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.接受持续性不卧床腹膜透析（PD）的婴儿接种白喉、破伤风和风疹疫苗后的抗体水平：儿科腹膜透析研究联盟的一项研究
Adv Perit Dial. 1997;13:297-9.
4
Determination of neutralizing antibodies and specific immunoglobulin isotype levels in infants after vaccination against diphtheria.
Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):341-5. doi: 10.1007/BF01962074.
5
Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid.白喉类毒素和破伤风类毒素与百日咳类毒素联合使用时免疫原性降低。
Pediatr Infect Dis J. 2005 Jan;24(1):85-6. doi: 10.1097/01.inf.0000148929.91719.10.
6
IgG and IgG subclass specific antibody responses to diphtheria and tetanus toxoids in newborns and infants given DTP immunization.接种百白破疫苗的新生儿和婴儿对白喉和破伤风类毒素的IgG及IgG亚类特异性抗体反应
Pediatr Res. 1986 Aug;20(8):735-9. doi: 10.1203/00006450-198608000-00007.
7
Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency.对因免疫缺陷而接受评估的儿童进行白喉/破伤风再接种后的特异性抗体反应。
Ann Allergy Asthma Immunol. 1997 Aug;79(2):145-50. doi: 10.1016/S1081-1206(10)63101-8.
8
Quantitative estimation of diphtheria and tetanus toxoids. 4. Toxoids as international reference materials defining Lf-units for diphtheria and tetanus toxoids.白喉和破伤风类毒素的定量测定。4. 作为定义白喉和破伤风类毒素Lf单位的国际参考物质的类毒素。
Biologicals. 1990 Jan;18(1):11-7. doi: 10.1016/1045-1056(90)90063-6.
9
Polyspecific human and murine antibodies to diphtheria and tetanus toxoids and phospholipids.针对白喉类毒素、破伤风类毒素和磷脂的多特异性人源和鼠源抗体。
Clin Exp Immunol. 1988 Aug;73(2):191-7.
10
Adjuvanticity of pGPL-Mc and LRS in the immune responses of monkeys to oral immunization with diphtheria and tetanus toxoids.pGPL-Mc和LRS对猴子口服白喉和破伤风类毒素免疫反应的佐剂效应。
Comp Immunol Microbiol Infect Dis. 1997 Jan;20(1):13-20. doi: 10.1016/s0147-9571(96)00030-6.

引用本文的文献

1
Tetanus and Diphtheria Toxoid-Containing Vaccine in Multiple Sclerosis Patients: A Real-World Prospective, Open-Label, Multi-Centre Study.破伤风和白喉类毒素疫苗在多发性硬化症患者中的应用：一项真实世界的前瞻性、开放标签、多中心研究。
Vaccines (Basel). 2025 Apr 24;13(5):451. doi: 10.3390/vaccines13050451.
2
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review.新冠病毒疫苗接种后多发性硬化症 (MS) 和视神经脊髓炎谱系障碍 (NMOSD)：系统评价。
Rev Neurol (Paris). 2023 Apr;179(4):265-281. doi: 10.1016/j.neurol.2022.11.004. Epub 2023 Jan 17.
3
Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective.感染、疫苗与自身免疫：多发性硬化症视角
Vaccines (Basel). 2020 Jan 28;8(1):50. doi: 10.3390/vaccines8010050.
4
Description and utilization of the United States department of defense serum repository: a review of published studies, 1985-2012.美国国防部血清库的描述与利用：1985年至2012年已发表研究综述
PLoS One. 2015 Feb 27;10(2):e0114857. doi: 10.1371/journal.pone.0114857. eCollection 2015.

本文引用的文献

1
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.血清25-羟基维生素D水平与多发性硬化症风险
JAMA. 2006 Dec 20;296(23):2832-8. doi: 10.1001/jama.296.23.2832.
2
Tetanus vaccination and risk of multiple sclerosis: a systematic review.破伤风疫苗接种与多发性硬化症风险：一项系统综述。
Neurology. 2006 Jul 25;67(2):212-5. doi: 10.1212/01.wnl.0000225079.51201.f9.
3
Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial.
Nat Med. 1996 Oct;2(10):1109-15. doi: 10.1038/nm1096-1109.
4
Intrathecal synthesis of antibodies to diphtheria and tetanus toxoids in multiple sclerosis patients.
J Neuroimmunol. 1981 Sep;1(3):333-41. doi: 10.1016/0165-5728(81)90036-9.
5
Use of prior vaccinations for the development of new vaccines.
Science. 1990 Jul 27;249(4967):423-5. doi: 10.1126/science.1696030.
6
Immunological features in multiple sclerosis.多发性硬化症的免疫学特征
Br Med J. 1976 Jan 24;1(6003):183-6. doi: 10.1136/bmj.1.6003.183.

抗破伤风和白喉类毒素IgG抗体的血清滴度与多发性硬化症风险

Serum titers of IgG antibodies against tetanus and diphtheria toxoids and risk of multiple sclerosis.

作者信息

Massa J, Munger K L, O'Reilly E J, Levin L I, Ascherio A

机构信息

Department of Nutrition, Harvard School of Public Health, Boston, MA, 02115, USA.

出版信息

J Neuroimmunol. 2009 Mar 31;208(1-2):141-2. doi: 10.1016/j.jneuroim.2009.01.006. Epub 2009 Feb 7.

DOI:10.1016/j.jneuroim.2009.01.006
PMID:19201486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2685194/
Abstract

We conducted a prospective nested case-control study among military service members to investigate whether antibodies against tetanus or diphtheria predict multiple sclerosis (MS) risk. Paired T-tests were used to compare means of anti-tetanus and diphtheria toxoids among 56 MS cases and 112 matched controls. Conditional logistic regression was used to estimate odds ratios (OR). There were no differences between the mean serum IgG antibodies against tetanus (p-value 0.28) or diphtheria (p-value 0.45) in the baseline samples. The OR of MS associated with 1 standard deviation difference in antibody titers was 0.76 (95% CI: 0.48-1.21) for tetanus (SD=4.71) and 1.03 (0.73-1.45) for diphtheria (SD=0.87). Results of this study suggest serum IgG antibodies against tetanus or diphtheria are not predictors of MS risk.

摘要

我们在军人中开展了一项前瞻性巢式病例对照研究，以调查破伤风或白喉抗体是否可预测多发性硬化症（MS）风险。采用配对t检验比较56例MS病例和112例匹配对照中抗破伤风和白喉类毒素的均值。使用条件逻辑回归估计比值比（OR）。基线样本中抗破伤风（p值0.28）或抗白喉（p值0.45）的血清IgG抗体均值无差异。破伤风抗体滴度相差1个标准差时MS的OR为0.76（95%CI：0.48-1.21）（标准差=4.71），白喉抗体滴度相差1个标准差时MS的OR为1.03（0.73-1.45）（标准差=0.87）。本研究结果表明，抗破伤风或抗白喉血清IgG抗体并非MS风险的预测指标。